Advanced search
Publication Cover
Scandinavian Journal of Rheumatology Volume 23, 1994 - Issue 6
Submit an article Journal homepage
20
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Side Effects of Sulphasalazine in Patients with Rheumatic Diseases or Inflammatory Bowel Disease

K. Laasila Second Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
&
M. Leirisalo-Repo Second Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Pages 338-340 | Received 21 Feb 1994, Accepted 05 Aug 1994, Published online: 12 Jul 2009

References

  • van Wijnands M JHT, Hof M A, van de Putte L BA, Van Kiel P LCM. Rheumatoid arthritis: A risk factor for sulphasalazine toxicity? A meta-analysis. Br J Rheumatol 1993; 32: 313–8
  • Felson D T, Anderson J J, Meenan RF. The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis. Results of Two Meta-analyses. Arthritis Rheum 1990; 33: 1449–61
  • The Australian Multicentre Clinical trial Group. Sulphasalazine in early rheumatoid arthritis. J Rheumatol 1992; 19: 1672–7
  • Porter D, Madhok R, Hunter J A, Capell HA. Prospective trial comparing the use of sulphasalazine and auranofin as second line drugs in patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 461–4
  • Pullar T, Hunter J A, Capell HA. Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate. BMJ 1983; 287: 1102–1
  • Dougados M, Maetzel A, Mijiyawa M, Amor B. Evaluation of sulphasalazine in the treatment of spondyloarthropathies. Ann Rheum Dis 1992; 51: 955–8
  • Nissilä M, Lehtinen K, Leirisalo-Repo M, Luukkanen R, Mutru O, Yli-Kerttula U. Sulphasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, Placebo-Controlled Clinical trial. Arthritis Rheum 1988; 31: 111, 1–6
  • Peppercorn MA. Sulphasalazine Pharmacology, Clinical Use, Toxicity, and Related New Drug Development. Ann Intern Med 1984; 3: 377–86
  • Das KM. Sulphasalazine therapy in inflammatory bowel disease. Gastroenterol Clin North Am 1989; 18: 1–20
  • Mulder C JJ, Tytgat G NJ, Weterman I T, Dekker W, Blok P, Schrijver Mv. d. Heide H. Double-blind comparison of slowrelease 5-aminosalicylate and sulphasalazine in remission maintenance in ulcerative colitis. Gastroenterology 1988; 95: 1449–52
  • Donovan S, Hawley S, MacCarthy J, Scott DL. Tolerability of enteric coated sulphasalazine in rheumatoid arthritis: Results of a co-operating clinics study. Br J Rheumatol 1990; 29: 201–4
  • Astbury C, Taggart A J, Juby L, Zebouni L, Bird HA. Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease. Ann Rheum Dis 1990; 49: 587–90
  • Farmer RG. Inflammatory bowel disease. Clin Gastroenterol 1980; 9: 229–481

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.